{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:30:17Z","timestamp":1772083817662,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["K08HL150169"],"award-info":[{"award-number":["K08HL150169"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","award":["KL2 TR002317"],"award-info":[{"award-number":["KL2 TR002317"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","award":["TL1 TR002318"],"award-info":[{"award-number":["TL1 TR002318"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","award":["UL1 TR002319"],"award-info":[{"award-number":["UL1 TR002319"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013382","name":"Institute of Translational Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ajogmf.2022.100671","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T23:40:00Z","timestamp":1653608400000},"page":"100671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association of fetal fraction with hypertensive disorders of pregnancy incidence and disease severity"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2747-2097","authenticated-orcid":false,"given":"Raj","family":"Shree","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodora R.","family":"Kolarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayley J.","family":"MacKinnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina M.","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchitra","family":"Chandrasekaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2022.100671_bib0001","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/clinchem\/46.12.1903","article-title":"Fetal DNA in maternal plasma: biology and diagnostic applications","volume":"46","author":"Lo","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0002","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","article-title":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics, Committee on Genetics, Society for Maternal-Fetal Medicine. Screening for fetal chromosomal abnormalities: ACOG Practice Bulletin, Number 226","volume":"136","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0003","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/gim.2016.97","article-title":"Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics","volume":"18","author":"Gregg","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0004","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/pd.5832","article-title":"International Society for Prenatal Diagnosis Position Statement: cell free (cf)DNA screening for Down syndrome in multiple pregnancies","volume":"41","author":"Palomaki","year":"2021","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0005","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/uog.18993","article-title":"Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia","volume":"52","author":"Rolnik","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0006","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2019.04.002","article-title":"Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy","volume":"16","author":"Gerson","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0007","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0008","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.5077","article-title":"Association of preeclampsia with incident stroke in later life among women in the Framingham heart study","volume":"4","author":"de Havenon","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0009","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/pd.6034","article-title":"Low fetal fraction in cell-free DNA testing is associated with adverse pregnancy outcome: analysis of a subcohort of the TRIDENT-2 study","volume":"41","author":"Becking","year":"2021","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0010","first-page":"1","article-title":"Fetal fraction of cell free DNA in screening for hypertensive disorders at 11-13 weeks","author":"Sapantzoglou","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0011","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.preghy.2020.07.015","article-title":"Association between low fetal fraction of cell free DNA at the early second-trimester and adverse pregnancy outcomes","volume":"22","author":"Yuan","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0012","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-0038-1667374","article-title":"Association of fetal fraction of cell-free DNA and hypertensive disorders of pregnancy","volume":"36","author":"Bender","year":"2019","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0039-1694005","article-title":"High fetal fraction on first trimester cell-free DNA aneuploidy screening and adverse pregnancy outcomes","volume":"37","author":"Shook","year":"2020","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0014","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/AOG.0000000000000363","article-title":"Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort","volume":"124","author":"Pergament","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/pd.4541","article-title":"Circulating cell free DNA testing: are some test failures informative?","volume":"35","author":"Palomaki","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0016","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0017","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000358326","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis","volume":"35","author":"Gil","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0018","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/AOG.0000000000002752","article-title":"Influence of body mass index on fetal fraction increase with gestation and cell-free DNA test failure","volume":"132","author":"Rolnik","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0019","article-title":"Obesity and cell-free DNA \u201cno calls\u201d: is there an optimal gestational age at time of sampling?","volume":"216","author":"Livergood","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0020","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/pd.6023","article-title":"Low fetal fraction in obese women at first trimester cell-free DNA based prenatal screening is not accompanied by differences in total cell-free DNA","volume":"41","author":"Shree","year":"2021","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0021","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/pd.5152","article-title":"The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction","volume":"37","author":"Burns","year":"2017","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0022","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/pd.5695","article-title":"Nonreportable rates and cell-free DNA profiles in noninvasive prenatal testing among women with heparin treatment","volume":"40","author":"Nakamura","year":"2020","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0023","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/pd.4668","article-title":"The influence of low molecular weight heparin medication on plasma DNA in pregnant women","volume":"35","author":"Gr\u00f6mminger","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0024","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12967-018-1705-2","article-title":"Autoimmune disorders but not heparin are associated with cell-free fetal DNA test failure","volume":"16","author":"Dabi","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0025","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0026","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0028","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.1073\/pnas.1406103111","article-title":"Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing","volume":"111","author":"Yu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0029","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1517\/17530059.2012.659726","article-title":"Recent biomarkers for the identification of patients at risk for preeclampsia: the role of uteroplacental ischemia","volume":"6","author":"Espinoza","year":"2012","journal-title":"Expert Opin Med Diagn"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/uog.14671","article-title":"Maternal plasma cell-free DNA in the prediction of pre-eclampsia","volume":"45","author":"Rolnik","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0031","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1080\/14737159.2021.1997593","article-title":"Cell-free DNA as a potential biomarker for preeclampsia","volume":"21","author":"Palei","year":"2021","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0032","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0033","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ajh.2008.20","article-title":"Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004","volume":"21","author":"Wallis","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0034","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","article-title":"Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin","volume":"164","author":"Snyder","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0035","doi-asserted-by":"crossref","first-page":"eaaw3616","DOI":"10.1126\/science.aaw3616","article-title":"Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies","volume":"372","author":"Lo","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0036","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021477","article-title":"At preeclampsia diagnosis, total cell-free DNA concentration is elevated and correlates with disease severity","volume":"10","author":"Kolarova","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0037","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1096\/fj.201600781r","article-title":"Considering sex as a biological variable in preclinical research","volume":"31","author":"Miller","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0038","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1089\/jwh.2019.8247","article-title":"Sex as a biological variable: a 5-year progress report and call to action","volume":"29","author":"Arnegard","year":"2020","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0039","doi-asserted-by":"crossref","first-page":"16456","DOI":"10.1038\/s41598-020-73350-3","article-title":"Diurnal stability of cell-free DNA and cell-free RNA in human plasma samples","volume":"10","author":"Wagner","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajogmf.2022.100671_bib0040","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ebiom.2019.10.008","article-title":"Day-to-day and within-day biological variation of cell-free DNA","volume":"49","author":"Madsen","year":"2019","journal-title":"EBiomedicine"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933322001069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933322001069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:51:10Z","timestamp":1762905070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933322001069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2589933322001069"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100671","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of fetal fraction with hypertensive disorders of pregnancy incidence and disease severity","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100671"}}